As of 2025-09-13, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 3.46 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 6.34 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -45.4%.
The range of the Relative Valuation is 2.55 - 4.26 CAD.
| Range | Selected | |
| Trailing P/E multiples | 664.5x - 992.9x | 828.7x |
| Forward P/E multiples | 34.2x - 45.3x | 39.8x |
| Fair Price | 2.55 - 4.26 | 3.46 |
| Upside | -59.7% - -32.9% | -45.4% |
| Date | P/E |
| 2025-09-09 | 1,672.98 |
| 2025-09-08 | 1,678.18 |
| 2025-09-05 | 1,675.58 |
| 2025-09-04 | 1,675.58 |
| 2025-09-03 | 1,683.38 |
| 2025-09-02 | 1,678.18 |
| 2025-08-29 | 1,691.19 |
| 2025-08-28 | 1,665.17 |
| 2025-08-27 | 1,688.59 |
| 2025-08-26 | 1,691.19 |
| 2025-08-25 | 1,701.60 |
| 2025-08-22 | 1,678.18 |
| 2025-08-21 | 1,657.36 |
| 2025-08-20 | 1,667.77 |
| 2025-08-19 | 1,662.57 |
| 2025-08-18 | 1,639.15 |
| 2025-08-15 | 1,618.34 |
| 2025-08-14 | 1,626.14 |
| 2025-08-13 | 1,652.16 |
| 2025-08-12 | 1,670.37 |
| 2025-08-11 | 1,688.59 |
| 2025-08-08 | 1,646.96 |
| 2025-08-07 | 1,665.17 |
| 2025-08-06 | 1,636.55 |
| 2025-08-05 | 1,631.35 |
| 2025-08-01 | 1,605.33 |
| 2025-07-31 | 1,584.51 |
| 2025-07-30 | 1,589.72 |
| 2025-07-29 | 1,597.52 |
| 2025-07-28 | 1,600.12 |
| 2025-07-25 | 1,600.12 |
| 2025-07-24 | 1,594.92 |
| 2025-07-23 | 1,592.32 |
| 2025-07-22 | 1,589.72 |
| 2025-07-21 | 1,561.10 |
| 2025-07-18 | 1,574.11 |
| 2025-07-17 | 1,615.73 |
| 2025-07-16 | 1,576.71 |
| 2025-07-15 | 1,579.31 |
| 2025-07-14 | 1,584.51 |
| 2025-07-11 | 1,594.92 |
| 2025-07-10 | 1,597.52 |
| 2025-07-09 | 1,587.11 |
| 2025-07-08 | 1,581.91 |
| 2025-07-07 | 1,571.50 |
| 2025-07-04 | 1,574.11 |
| 2025-07-03 | 1,566.30 |
| 2025-07-02 | 1,561.10 |
| 2025-06-30 | 1,516.87 |
| 2025-06-27 | 1,496.05 |